These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2555445)

  • 1. Predilection of a nasopharyngeal carcinoma-derived isolate of Epstein-Barr virus for infection of specific subsets of B lymphocytes.
    Tarr KL; Glaser R
    J Med Virol; 1989 Sep; 29(1):47-52. PubMed ID: 2555445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene mapping of an Epstein-Barr virus isolate obtained from a nasopharyngeal carcinoma.
    Zhang HY; Dangel A; Takimoto T; Glaser R
    Intervirology; 1989; 30(1):52-60. PubMed ID: 2542179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines.
    Takimoto T; Umeda R; Glaser R
    Acta Virol; 1989 Aug; 33(4):375-7. PubMed ID: 2574946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma.
    Takimoto T; Umeda R
    Acta Virol; 1989 Aug; 33(4):314-9. PubMed ID: 2574937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2.
    Billaud M; Busson P; Huang D; Mueller-Lantzch N; Rousselet G; Pavlish O; Wakasugi H; Seigneurin JM; Tursz T; Lenoir GM
    J Virol; 1989 Oct; 63(10):4121-8. PubMed ID: 2550660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marmoset lymphoblastoid cells transformed by NPC-KT-derived Epstein-Barr virus which possesses transforming and superinfecting characteristics.
    Takimoto T; Sato H; Ogura H; Ogura T; Ishikawa S; Iwawaki J
    ORL J Otorhinolaryngol Relat Spec; 1987; 49(4):169-74. PubMed ID: 2819802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
    Cohen JH; Fischer E; Kazatchkine MD; Lenoir GM; Lefevre-Delvincourt C; Revillard JP
    Scand J Immunol; 1987 Jun; 25(6):587-98. PubMed ID: 3037684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
    Church TM; Verma D; Thompson J; Swaminathan S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.
    Calender A; Billaud M; Aubry JP; Banchereau J; Vuillaume M; Lenoir GM
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8060-4. PubMed ID: 2825176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal versus polyclonal Epstein-Barr virus infection in nasopharyngeal carcinoma cell lines.
    Lin CT; Chen W; Hsu MM; Dee AN
    Lab Invest; 1997 Jun; 76(6):793-8. PubMed ID: 9194855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell fusion by nasopharyngeal carcinoma-derived Epstein-Barr virus.
    Takimoto T; Sato H; Ogura H; Miyazaki T
    Arch Otolaryngol Head Neck Surg; 1987 May; 113(5):510-3. PubMed ID: 3032215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV)-lymphoid cell interactions. I. Quantification of EBV particles required for the membrane immunofluorescence assay and the comparative expression of EBV receptors on different human B, T and null cell lines.
    Patel P; Menezes J
    J Gen Virol; 1981 Mar; 53(Pt 1):1-11. PubMed ID: 6268736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.
    Rickinson AB; Young LS; Rowe M
    J Virol; 1987 May; 61(5):1310-7. PubMed ID: 3033261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinoma biopsies.
    Wang Y; Wang XF; Sun ZF; Luo B
    Virus Res; 2012 Jun; 166(1-2):23-30. PubMed ID: 22406129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
    Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.
    Glaser R; Zhang HY; Yao KT; Zhu HC; Wang FX; Li GY; Wen DS; Li YP
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9524-8. PubMed ID: 2556716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
    Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
    Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth transformation of primary epithelial cells with a NPC-derived Epstein-Barr virus strain.
    Danve C; Decaussin G; Busson P; Ooka T
    Virology; 2001 Sep; 288(2):223-35. PubMed ID: 11601894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.